Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 14 February 2019 |
| Author/s |
author: Ghazaleh Tabatabai Jörg-Christian Tonn Elke Hattingen Astrid Weyerbrock Peter Vajkoczy Wolfgang Wick Martin Coenen Matthias Schmid Peter Hau |
| Publication date | February 14, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |